The classic executive objection: "the AI Act value gap is your sales argument." One-line answer — it isn't ours, it's a leading audit firm's.
Because it comes from a leading audit firm, in a note on M&A due diligence, and it links by name three things the market had been treating separately: compliance (GDPR + EU AI Act), legal exposure, and valuation. This isn't "compliance is good." It's "non-compliance damages the price."
a leading audit firm isn't alone. Brown Rudnick describes compliance as the "golden ticket to exit." Bain puts at one in five the acquirers who walked away from an AI deal in 2026. FE International estimates the multiple reduction tied to regulatory and technical risk at 15-30%. The consensus is in place across the entire advisory market.
The diagnosis is shared. What didn't exist was the means to quantify it per asset, fast, and defensibly. That's precisely the function of the D7™ score: characterizing an asset's EU AI Act exposure across 7 dimensions, with an evidence level for each claim. Where a leading audit firm describes the risk to value, D7™ measures it — on your asset, not in the abstract.